SCT · NZX

Scott Technology (SCT)

Industrials / Automation and roboticsCovered: FY21 - HY2610 published briefings

Scott Technology is an NZX-listed industrials / automation and robotics company with FY21 - HY26 of published result briefings.

Sections

Snapshot

Latest metrics

HY26, released 15 April 2026

← Swipe to view more

SCT latest metrics
Metric	Value	Change
Revenue	$128.2m	↑ +5.3%
EBITDA	$13m	↑ +7.0%
NPAT	$4.3m	↓ -2.3%
Operating cash flow	$6.1m	↓ -57.9%
OCF / EBITDA %	46.9%	↓ -72.4pp
Net debt	$13.1m	↓ -0.5%
Net debt / EBITDA	1x	↓ -7.4%
ROE %	3.3%	↓ -0.3pp
DPS	4.0c	↑ +33.3%
Payout ratio vs NPAT %	76.9%	↑ +21.3pp

Source: latest published briefing (HY26, released 15 April 2026). Change compares against the prior equivalent period: HY25, released 16 April 2025.

Valuation

A compact read on what the market price implies next to the latest filing data. The numbers are a starting point for comparison, not a recommendation.

Prices as at close, 16 June 2026

Price and market cap

The latest close and share count context for the market price.

Market cap

$227.5m

End-of-day close multiplied by current shares on issue.

Profitability multiples

How the market price compares with recent earnings and cash-flow inputs.

P/E

15.91x

Recent market cap compared with trailing earnings.

EPS

0.17

Recent filing-derived earnings per share.

PEG

Not available

Not meaningful without positive comparable earnings growth.

EV/EBITDA

7.43x

Enterprise value compared with recent EBITDA.

P/FCF

23.05x

Market cap compared with recent free cash flow.

P/B

1.74x

Market value compared with latest reported equity.

Income and fund shape

Yield and fund-style valuation where the company shape supports it.

Dividend yield

3.4%

Trailing dividends compared with the latest close.

Total return

Not available

Available once dividend and adjustment data are verified.

Price history

Daily closes use the full available width, with hover and touch readouts against real observations. Expand opens the chart at reading size.

Share price

Five years of daily closes, as at close, 5 June 2026. Weekends, suspensions, and listing gaps stay as natural gaps in the time scale.

Loading chart...

Price vs earnings

Indexed lines compare direction from the first positive comparable filing point. The axis is an index, not dollars or cents.

Loading chart...

Chat

Ask about SCT

Ask follow-up questions about Scott Technology's latest result and company history.

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Ask about SCT

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Longitudinal view

Performance over time

The latest period is shown first.

← Swipe to view more

SCT metric history
Metric	HY266 MONTHS15 April 2026	FY2512 MONTHS21 October 2025	HY256 MONTHS16 April 2025	FY2412 MONTHS17 October 2024	HY246 MONTHS16 April 2024	FY2312 MONTHS18 October 2023	HY236 MONTHS12 April 2023	FY2212 MONTHS18 October 2022	HY226 MONTHS7 April 2022	FY2112 MONTHS21 October 2021	Trend
Revenue	$128.2m	$275.3m	$121.7m	$276.1m	$140.9m	$267.5m	$126.5m	$221.8m	$118.4m	$216.2m	Chart
Revenue growth %	5.3%	-0.3%Outside range low revenue growth. -0.3%; 4-period range 2.6% to 20.6%. Revenue growth: -0.3%, below normal range; 4-period mean 10.7%, range 2.6%-20.6%.	-13.6%Unprecedented low revenue growth. -13.6%; 4-period range 5.3% to 13.3%. Revenue growth: -13.6%, unprecedented low; 4-period mean 9.2%, range 5.3%-13.3%.	3.2%	11.3%	20.6%Unprecedented high revenue growth. 20.6%; 4-period range -0.3% to 16.2%. Revenue growth: 20.6%, unprecedented high; 4-period mean 5.4%, range -0.3%-16.2%.	6.9%	2.6%	13.3%Outside range high revenue growth. 13.3%; 4-period range -13.6% to 11.3%. Revenue growth: 13.3%, above normal range; 4-period mean 2.5%, range -13.6%-11.3%.	16.2%	Chart HY25 Revenue growth %: Unprecedented low revenue growth. -13.6%; 4-period range 5.3% to 13.3%. Revenue growth: -13.6%, unprecedented low; 4-period mean 9.2%, range 5.3%-13.3%. FY25 Revenue growth %: Outside range low revenue growth. -0.3%; 4-period range 2.6% to 20.6%. Revenue growth: -0.3%, below normal range; 4-period mean 10.7%, range 2.6%-20.6%.
EBITDA	$13m	$31.5m	$12.2m	$30.2m	$16.6m	$30.4m	$14.6m	$23.9m	$12.2m	$22.1m	Chart
EBITDA margin %	10.2%	11.5%Outside range high ebitda margin. 11.5%; 4-period range 10.2% to 11.3%. EBITDA margin: 11.5%, above normal range; 4-period mean 10.8%, range 10.2%-11.3%.	10.0%Outside range low ebitda margin. 10%; 4-period range 10.2% to 11.8%. EBITDA margin: 10.0%, below normal range; 4-period mean 10.9%, range 10.2%-11.8%.	10.9%	11.8%Unprecedented high ebitda margin. 11.8%; 4-period range 10% to 11.5%. EBITDA margin: 11.8%, unprecedented high; 4-period mean 10.5%, range 10.0%-11.5%.	11.4%	11.5%	10.8%	10.3%	10.2%Unprecedented low ebitda margin. 10.2%; 4-period range 10.8% to 11.5%. EBITDA margin: 10.2%, unprecedented low; 4-period mean 11.1%, range 10.8%-11.5%.	Chart HY24 EBITDA margin %: Unprecedented high ebitda margin. 11.8%; 4-period range 10% to 11.5%. EBITDA margin: 11.8%, unprecedented high; 4-period mean 10.5%, range 10.0%-11.5%. HY25 EBITDA margin %: Outside range low ebitda margin. 10%; 4-period range 10.2% to 11.8%. EBITDA margin: 10.0%, below normal range; 4-period mean 10.9%, range 10.2%-11.8%. FY25 EBITDA margin %: Outside range high ebitda margin. 11.5%; 4-period range 10.2% to 11.3%. EBITDA margin: 11.5%, above normal range; 4-period mean 10.8%, range 10.2%-11.3%.
PBT	$5.9m	$17.4m	$5m	$11m	$6.1m	$19.2m	$9.7m	$14.9m	$7.4m	$12m	Chart
PBT growth %	18.0%	58.2%	-18.0%	-42.7%Unprecedented low pbt growth. -42.7%; 4-period range 24.2% to 151.2%. PBT growth: -42.7%, unprecedented low; 4-period mean 65.6%, range 24.2%-151.2%.	-37.1%Unprecedented low pbt growth. -37.1%; 4-period range -18% to 31.1%. PBT growth: -37.1%, unprecedented low; 4-period mean 13.1%, range -18.0%-31.1%.	28.9%	31.1%Outside range high pbt growth. 31.1%; 4-period range -37.1% to 21.3%. PBT growth: 31.1%, above normal range; 4-period mean -3.9%, range -37.1%-21.3%.	24.2%	21.3%	—	Chart HY24 PBT growth %: Unprecedented low pbt growth. -37.1%; 4-period range -18% to 31.1%. PBT growth: -37.1%, unprecedented low; 4-period mean 13.1%, range -18.0%-31.1%. FY24 PBT growth %: Unprecedented low pbt growth. -42.7%; 4-period range 24.2% to 151.2%. PBT growth: -42.7%, unprecedented low; 4-period mean 65.6%, range 24.2%-151.2%.
NPAT	$4.3m	$14.4m	$4.4m	$7.9m	$4.4m	$15.4m	$7.9m	$0.1m	$4.7m	$9.6m	Chart
NPAT growth %	0.0%	82.3%	0.0%	-48.7%	-44.3%Unprecedented low npat growth. -44.3%; 4-period range 0% to 68.1%. NPAT growth: -44.3%, unprecedented low; 4-period mean 17.0%, range 0.0%-68.1%.	n/m	68.1%Unprecedented high npat growth. 68.1%; 4-period range -44.3% to 0%. NPAT growth: 68.1%, unprecedented high; 4-period mean -11.1%, range -44.3%-0.0%.	-99.0%	0.0%	—	Chart HY24 NPAT growth %: Unprecedented low npat growth. -44.3%; 4-period range 0% to 68.1%. NPAT growth: -44.3%, unprecedented low; 4-period mean 17.0%, range 0.0%-68.1%.
Operating cash flow	$6.1m	$22.3m	$14.5m	$6m	-$7.7m	$20.2m	$26m	$6.3m	-$8.8m	$13.4m	Chart
OCF / EBITDA %	46.9%	70.7%Outside range high ocf / ebitda cash conversion. 70.7%; 4-period range 19.8% to 66.6%. OCF / EBITDA cash conversion: 70.7%, above normal range; 4-period mean 43.4%, range 19.8%-66.6%.	119.3%	19.8%Unprecedented low ocf / ebitda cash conversion. 19.8%; 4-period range 26.4% to 70.7%. OCF / EBITDA cash conversion: 19.8%, unprecedented low; 4-period mean 56.1%, range 26.4%-70.7%.	-46.5%	66.6%	178.7%Unprecedented high ocf / ebitda cash conversion. 178.8%; 4-period range -72.7% to 119.3%. OCF / EBITDA cash conversion: 178.8%, unprecedented high; 4-period mean 11.7%, range -72.7%-119.3%.	26.4%	-72.7%	60.7%	Chart FY24 OCF / EBITDA %: Unprecedented low ocf / ebitda cash conversion. 19.8%; 4-period range 26.4% to 70.7%. OCF / EBITDA cash conversion: 19.8%, unprecedented low; 4-period mean 56.1%, range 26.4%-70.7%. FY25 OCF / EBITDA %: Outside range high ocf / ebitda cash conversion. 70.7%; 4-period range 19.8% to 66.6%. OCF / EBITDA cash conversion: 70.7%, above normal range; 4-period mean 43.4%, range 19.8%-66.6%.
FCF pre-lease	$4.4m	$18.2m	$12.7m	-$4.4m	-$12.8m	$14.7m	$24.5m	-$2.6m	-$10m	$8.9m	Chart
FCF post-lease	—	—	—	-$4.4m	—	—	—	—	—	—	—
DPS	4.0c	5.0c	3.0c	3.0c	5.0c	4.0c	4.0c	4.0c	4.0c	4.0c	Chart
Payout ratio vs NPAT %	76.9%	46.0%	55.6%	82.5%Unprecedented high payout ratio versus npat. 82.5%; 4-period range 41.5% to 50.3%. Payout ratio versus NPAT: 82.5%, unprecedented high; 4-period mean 46.7%, range 41.5%-50.3%.	90.9%Unprecedented high payout ratio versus npat. 90.9%; 4-period range 40.8% to 76.9%. Payout ratio versus NPAT: 90.9%, unprecedented high; 4-period mean 60.0%, range 40.8%-76.9%.	41.5%Outside range low payout ratio versus npat. 41.5%; 4-period range 46% to 82.5%. Payout ratio versus NPAT: 41.5%, below normal range; 4-period mean 56.9%, range 46.0%-82.5%.	40.8%Unprecedented low payout ratio versus npat. 40.8%; 4-period range 55.6% to 90.9%. Payout ratio versus NPAT: 40.8%, unprecedented low; 4-period mean 72.5%, range 55.6%-90.9%.	50.3%	66.7%	48.8%	Chart HY24 Payout ratio vs NPAT %: Unprecedented high payout ratio versus npat. 90.9%; 4-period range 40.8% to 76.9%. Payout ratio versus NPAT: 90.9%, unprecedented high; 4-period mean 60.0%, range 40.8%-76.9%. FY24 Payout ratio vs NPAT %: Unprecedented high payout ratio versus npat. 82.5%; 4-period range 41.5% to 50.3%. Payout ratio versus NPAT: 82.5%, unprecedented high; 4-period mean 46.7%, range 41.5%-50.3%.
Annual payout ratio vs EPS %	—	46.0%	—	82.5%	—	41.5%	—	50.3%	—	48.8%	Chart
ROE %	3.3%	11.1%	3.6%Outside range low roe. 3.6%; 3-period range 3.9% to 14.9%. ROE: 3.6%, below normal range; 3-period mean 7.8%, range 3.9%-14.9%.	7.0%	3.9%	13.5%Outside range high roe. 13.5%; 4-period range 0.1% to 11.1%. ROE: 13.5%, above normal range; 4-period mean 7.0%, range 0.1%-11.1%.	14.9%Outside range high roe. 14.9%; 3-period range 3.6% to 4.5%. ROE: 14.9%, above normal range; 3-period mean 4.0%, range 3.6%-4.5%.	0.1%Unprecedented low roe. 0.1%; 4-period range 7% to 13.5%. ROE: 0.1%, unprecedented low; 4-period mean 10.3%, range 7.0%-13.5%.	4.5%	9.8%	Chart HY25 ROE %: Outside range low roe. 3.6%; 3-period range 3.9% to 14.9%. ROE: 3.6%, below normal range; 3-period mean 7.8%, range 3.9%-14.9%.
Net debt	$13.1m	$12.3m	$13.2m	$20.1m	$20.7m	-$79m	-$12.8m	$8m	$12.9m	-$1.3m	Chart
Net debt / EBITDA	1x	0.39x	1.08x	0.66xUnprecedented high net debt / ebitda. 0.66x; 4-period range -0.06x to 0.4x. Net debt / EBITDA: 0.66x, unprecedented high; 4-period mean 0.16x, range -0.06x-0.40x.	1.25xOutside range high net debt / ebitda. 1.2x; 4-period range -0.88x to 1.1x. Net debt / EBITDA: 1.20x, above normal range; 4-period mean 0.57x, range -0.88x-1.10x.	-2.6x	-0.88x	0.34x	1.06x	-0.06x	Chart HY24 Net debt / EBITDA: Outside range high net debt / ebitda. 1.2x; 4-period range -0.88x to 1.1x. Net debt / EBITDA: 1.20x, above normal range; 4-period mean 0.57x, range -0.88x-1.10x. FY24 Net debt / EBITDA: Unprecedented high net debt / ebitda. 0.66x; 4-period range -0.06x to 0.4x. Net debt / EBITDA: 0.66x, unprecedented high; 4-period mean 0.16x, range -0.06x-0.40x.
Debtor days	64Unprecedented high debtor days. 64d; 4-period range 46d to 60d. Debtor days: 64.4 days, unprecedented high; 4-period mean 51.7 days, range 46.4 days-60.2 days.	79Unprecedented high debtor days. 79d; 4-period range 46d to 66d. Debtor days: 79.0 days, unprecedented high; 4-period mean 56.2 days, range 46.4 days-65.8 days.	60	53	46Outside range low debtor days. 46d; 4-period range 49d to 64d. Debtor days: 46.4 days, below normal range; 4-period mean 56.2 days, range 48.8 days-64.4 days.	60	51	66	49	46Outside range low debtor days. 46d; 4-period range 53d to 79d. Debtor days: 46.4 days, below normal range; 4-period mean 64.4 days, range 53.2 days-79.0 days.	Chart HY24 Debtor days: Outside range low debtor days. 46d; 4-period range 49d to 64d. Debtor days: 46.4 days, below normal range; 4-period mean 56.2 days, range 48.8 days-64.4 days. FY25 Debtor days: Unprecedented high debtor days. 79d; 4-period range 46d to 66d. Debtor days: 79.0 days, unprecedented high; 4-period mean 56.2 days, range 46.4 days-65.8 days. HY26 Debtor days: Unprecedented high debtor days. 64d; 4-period range 46d to 60d. Debtor days: 64.4 days, unprecedented high; 4-period mean 51.7 days, range 46.4 days-60.2 days.
Inventory days	64Unprecedented high inventory days. 64d; 4-period range 44d to 55d. Inventory days: 64.4 days, unprecedented high; 4-period mean 48.3 days, range 43.8 days-55.4 days.	52	55	49	47	52Outside range high inventory days. 52d; 4-period range 39d to 52d. Inventory days: 52.2 days, above normal range; 4-period mean 47.7 days, range 39.0 days-51.6 days.	47	52	44Outside range low inventory days. 44d; 4-period range 47d to 64d. Inventory days: 43.8 days, below normal range; 4-period mean 53.5 days, range 46.9 days-64.4 days.	39Unprecedented low inventory days. 39d; 4-period range 49d to 52d. Inventory days: 39.0 days, unprecedented low; 4-period mean 51.0 days, range 48.8 days-52.2 days.	Chart HY26 Inventory days: Unprecedented high inventory days. 64d; 4-period range 44d to 55d. Inventory days: 64.4 days, unprecedented high; 4-period mean 48.3 days, range 43.8 days-55.4 days.
Total assets	$268m	$269.6m	$244.4m	$244m	$255.8m	$253.1m	$241.6m	$206.9m	$210.8m	$194.5m	Chart

Reference: annolyse.ai/companies/sct

Note: Figures are shown as reported. Half-year and full-year absolute values are not directly comparable. Growth rates and ratios are the meaningful comparison across mixed periods.

Filing-only history charts

These charts use verified published filing periods only. Gaps are not interpolated, and mixed half-year/full-year histories are split into separate series.

Revenue

Reported revenue across covered periods.

Loading chart...

Revenue growth

Like-period revenue growth where comparable.

Loading chart...

EBITDA-equivalent

Company-specific earnings measure where disclosed.

Loading chart...

EBITDA margin

EBITDA-equivalent margin where revenue and earnings are source-backed.

Loading chart...

NPAT

Statutory profit after tax.

Loading chart...

Operating cash flow

Cash generated from operations.

Loading chart...

Full chartable metric set

Additional verified filing metrics for this company. Each point links back to a published briefing period in the source data contract.

OCF / EBITDA

Cash conversion against earnings.

Loading chart...

FCF pre-lease

Operating cash flow less capex before leases.

Loading chart...

FCF post-lease

Free cash flow after lease payments where available.

Loading chart...

ROE

Return on equity.

Loading chart...

Net debt

Borrowings less cash; negative values indicate net cash.

Loading chart...

Net debt / EBITDA

Leverage ratio, suppressed where earnings are not meaningful.

Loading chart...

DPS

Dividend per share declared for the period.

Loading chart...

Payout ratio

Dividend payout against statutory NPAT.

Loading chart...

Debtor days

Receivables days where the working-capital inputs are source-backed.

Loading chart...

Inventory days

Inventory days where the working-capital inputs are source-backed.

Loading chart...

Operating working-capital movement

Per-period working-capital absorption or release, from the same published history. Positive values are working-capital build; negative values are release.

Loading chart...

The setup & the reality

FY25 → HY26 Follow-through

The latest result is checked against what the prior briefing said to watch.

Historical setup

What FY25 said to watch

From PBT up 58% on margin lift, but receivable days stretched to 79

Forward work of $169m is up from $160m and represents roughly 61% of FY25 revenue, slightly better cover than a year ago. The release frames FY25 as second-half weighted: HY25 carried 44.2% of revenue, 38.6% of EBITDA and only 30.3% of NPAT, so the FY25 result leans heavily on H2 execution that may or may not annualise.

Against the stated Destination 2030 target of $530m revenue by FY30, the required revenue CAGR is around 14%, which is materially above what FY25 delivered. The release does not provide FY26 numerical guidance, so this briefing focuses on what the result does and does not support: it supports the margin-lift narrative, but it does not yet evidence the top-line acceleration the 2030 target implies.

Open questions

Open questions from FY25

What drove receivable days from 53 to 79 — was it a few large late-FY25 deliveries, slower customer sign-off, or a change in billing milestones across the project book?
Is the 60.2% drop in capex a deliberate reset or deferred spend that will return in FY26, and what does the Destination 2030 plan imply for medium-term capital intensity?
How much of the Materials Handling 4ppt gross-margin lift is contract mix versus modular delivery efficiency, and is that level repeatable?
Why did Appliances revenue fall to $31.4m from $40.1m with margin also softening, and is that a cyclical or structural shift?
What revenue trajectory does management see between FY25's $275m base and the $530m FY30 target, given the ~14% CAGR implied?

This briefing cannot assess customer-specific receivable ageing, the timing of post-year-end cash collection on the $59.6m debtor book, or the durability of the FY25 segment-margin mix without segment commentary on contract pipeline composition.

Briefing archive

Every published Annolyse briefing for this company appears here in reverse chronological order.

HY26 · Released 15 April 2026

Working capital absorbed $13.0m as debtor and inventory days hit new highs

PBT grew 18.0% and forward work climbed to $177m, but operating cash fell 58% on a working-capital build more than double the historical norm.

Read briefing

FY25 · Released 21 October 2025

PBT up 58% on margin lift, but receivable days stretched to 79

Materials Handling and Protein margins drove earnings on flat revenue, yet trade debtors absorbed $19.4m as days outstanding lengthened.

Read briefing

HY25 · Released 16 April 2025

Revenue fell 13.6% and PBT 18% but tax rate halved kept NPAT flat

Operating earnings dropped below their historical range while an unusually low tax charge and a smaller working-capital build lifted reported cash.

Read briefing

FY24 · Released 17 October 2024

Net debt swung to $20.1m as cash conversion collapsed to 19.8%

Operating cash fell 70.5% to $6.0m on essentially flat EBITDA, turning free cash flow negative and pushing leverage off a near-zero base.

Read briefing

HY24 · Released 16 April 2024

PBT fell 37.1% on 11.3% revenue growth as working capital absorbed NZ$25.9m

Strong EBITDA and revenue growth were overwhelmed by an unprecedented working-capital build and one-off costs that collapsed pre-tax profit

Read briefing

FY23 · Released 18 October 2023

Revenue +20.6% drives PBT +28.9% as net debt clears and margins expand

Strong full-year cash conversion masks a second-half operating cash outflow as contract assets and inventory built.

Read briefing

HY23 · Released 12 April 2023

PBT up 31.1% on margin highs, but working-capital release flatters cash

Margins reached an unprecedented 7.7% but the OCF swing leans on a working-capital release that breaks a three-period pattern of builds.

Read briefing

FY22 · Released 18 October 2022

PBT up 24.2% but cash conversion fell to 26.4% on working-capital build

Continuing operations strengthened, yet operating cash flow fell 53% and a $12.6m discontinued-operation loss wiped headline NPAT to near zero.

Read briefing

HY22 · Released 7 April 2022

Cash flow flipped to -NZ$8.8m on a NZ$14.9m working-capital build

Revenue rose 13.3% and PBT 21.3%, but inventory absorption and a doubled dividend pushed net debt/EBITDA to 1.06x from 0.26x.

Read briefing

FY21 · Released 21 October 2021

EBITDA swung to $22.1m on a 1,000bps gross margin gain, but OCF fell 31.4%

Revenue rose 16.2% and gross margin doubled to 23%, yet $6.3m working-capital absorption masked the underlying cash translation.

Read briefing

Get notified when SCT publishes

Get the next Scott Technology result briefing and five-year history updates by email.

Scott Technology (SCT)

Latest metrics

Valuation

Price and market cap

Profitability multiples

Income and fund shape

Price history

Share price

Price vs earnings

Ask about SCT

Ask about SCT

Sign in to chat

Performance over time

Filing-only history charts

Revenue

Revenue growth

EBITDA-equivalent

EBITDA margin

NPAT

Operating cash flow

Full chartable metric set

OCF / EBITDA

FCF pre-lease

FCF post-lease

ROE

Net debt

Net debt / EBITDA

DPS

Payout ratio

Debtor days

Inventory days

Operating working-capital movement

FY25 → HY26 Follow-through

What FY25 said to watch

Open questions from FY25

Briefing archive

Working capital absorbed $13.0m as debtor and inventory days hit new highs

PBT up 58% on margin lift, but receivable days stretched to 79

Revenue fell 13.6% and PBT 18% but tax rate halved kept NPAT flat

Net debt swung to $20.1m as cash conversion collapsed to 19.8%

PBT fell 37.1% on 11.3% revenue growth as working capital absorbed NZ$25.9m

Revenue +20.6% drives PBT +28.9% as net debt clears and margins expand

PBT up 31.1% on margin highs, but working-capital release flatters cash

PBT up 24.2% but cash conversion fell to 26.4% on working-capital build

Cash flow flipped to -NZ$8.8m on a NZ$14.9m working-capital build

EBITDA swung to $22.1m on a 1,000bps gross margin gain, but OCF fell 31.4%

Compare this company

Get notified when SCT publishes

Scott Technology (SCT)

Latest metrics

Valuation

Price and market cap

Profitability multiples

Income and fund shape

Price history

Share price

Price vs earnings

Ask about SCT

Ask about SCT

Sign in to chat

Performance over time

Filing-only history charts

Revenue

Revenue growth

EBITDA-equivalent

EBITDA margin

NPAT

Operating cash flow

Full chartable metric set

OCF / EBITDA

FCF pre-lease

FCF post-lease

ROE

Net debt

Net debt / EBITDA

DPS

Payout ratio

Debtor days

Inventory days

Operating working-capital movement